2 incredible ASX shares to buy in November

This could be a great time to buy these investments.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Pro Medicus Ltd, a leading healthcare informatics company, showcases impressive financials with a 74% EBIT margin and significant profit and revenue growth in FY25.
  • Despite a high P/E ratio, Pro Medicus continues to secure multi-year contracts, boosting future revenue prospects and offering robust investment potential.
  • The VanEck MSCI International Small Cos Quality ETF offers diversified exposure to high-ROE and low-leverage companies, averaging a 16% annual return over three years.

Owning the highest-quality ASX shares can deliver excellent returns because of the power of their brands, financials, market share and management.

Over the long-term, I'd expect a high-quality business to deliver more profit growth and share price growth compared to a mediocre company.

Of all of the options that Australians could choose for their portfolios, there are few options as high-quality as the ones below.

Blue light arrows pointing up, indicating a strong rising share price.

Image source: Getty Images

Pro Medicus Ltd (ASX: PME)

I believe Pro Medicus is one of, if not the, highest quality ASX shares. It describes itself as a leading healthcare informatics company. The company provides a full range of medical imaging software and services to hospitals, imaging centres and healthcare groups worldwide

Pro Medicus has incredibly high profit margins. In FY25, the company generated revenue of $213 million and it produced net profit after tax (NPAT) of $115.2 million with $157.7 million of underlying operating profit (EBIT). Its underlying EBIT margin of 74% is incredible.

A very large amount of new revenue is turned into profit. FY25 saw 31.9% revenue growth and 39.2% net profit after tax (NPAT) growth, which has helped propel Pro Medicus' share price higher. It continues winning new multi-year contracts, which will translate into significantly larger revenue in the coming years.

It is also successful at renewing contracts at a higher fee rate, as well as selling additional modules to existing customers.

It may still trade on a high price/earnings (P/E) ratio, but it's lower now after falling by more than 20% since mid-July 2025.

According to the forecasts on CMC Markets, the ASX share is trading at 124x FY27's estimated earnings.

VanEck MSCI International Small Cos Quality ETF (ASX: QSML)

I think small companies have tremendous growth potential because they are usually much earlier on with their growth journeys – they can still significantly scale from where they are today.

But, investing in small businesses can come with risk, so I'd want to only own good ones. How do you pick out the best ones to own? The QSML ETF could be an excellent option for a few reasons.

The exchange-traded fund (ETF) implements a few quality screening tests to ensure it just invests in the best of the best.

The QSML ETF only invests in businesses with a high return on equity (ROE), good earnings stability and low financial leverage. In other words, these businesses make high levels of profit on retained shareholder money, profit is usually growing and debt levels are low.

It invests in 150 of these high-quality small companies from across the world, with different sectors represented in the portfolio, so it's a diversified investment. Pleasingly, over the last three years, it has returned an average of 16% per year. I think this could still be a great time to invest in these small global companies for the long-term.

Motley Fool contributor Tristan Harrison has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

An army soldier in combat uniform takes a phone call in the field.
Opinions

Forget DroneShield shares, I'd buy these ASX defence stocks instead

These ASX defence stocks look like they have a better upside than DroneShield shares over the next 12 months.

Read more »

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Cheap Shares

3 super cheap ASX 200 shares I'd buy right now

These ASX 200 shares are trading at dirt-cheap prices right now.

Read more »

Happy woman looking for groceries. as she watches the Coles share price and Woolworths share price on her phone
Opinions

3 reasons why the Coles share price is a buy

It seems like a great time to invest in this supermarket giant.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Opinions

A rare buying opportunity in 1 of Australia's top shares?

This business looks very undervalued to me!

Read more »

5 mini houses on a pile of coins.
Opinions

2 ASX shares I'd much rather buy than an investment property

Certain ASX shares can offer exposure to real estate with more income potential.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Technology Shares

I was going to buy these ASX tech stocks. Now, I'm not so sure

When the facts change, so should our buying...

Read more »

A boy standing on the edge of a cliff peers at a red flag in the distance through binoculars.
Opinions

Are Pro Medicus shares a buy right now?

Pro Medicus shares are down 36% this year. What now?

Read more »

Young girl peeps over the top of her red piggy bank, ready to put coins in it.
Opinions

NAB shares: Are they cheap enough to buy after the latest drop?

NAB shares are down nearly 10%. Is this a buying window?

Read more »